Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 8/20 | 0.32 |
| ▸ | DRD3 | P35462 | 8/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10223600 | 1.00 | HSP90AA1 (0.34) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL10272153 | 0.89 | HSP90AA1 (0.33) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL604106 | 0.89 | HSP90AA1 (0.33) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL13066926 | 0.81 | HSP90AA1 (0.36) | HSP90AA1HSP90AB1CDK8CDK19DRD2 | |
| SCHEMBL10223614 | 0.81 | HSP90AA1 (0.40) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL603166 | 0.81 | HSP90AA1 (0.40) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL604337 | 0.77 | CYP3A4 (0.36) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL601204 | 0.77 | SMN1; SMN2 (0.36) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL10223595 | 0.77 | CYP3A4 (0.36) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 | |
| SCHEMBL604379 | 0.77 | HSD17B10 (0.46) | HSP90AA1HSP90AB1NPSR1CDK8CDK19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432780-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | Sumitomo Chemical Company, Limited (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-20120041009-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| WO-2010134478-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041009-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | TYMP, DPYD, TYMS | HSP90AA1 3094/4885HSP90AB1 3128/4885NPSR1 3600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.